Navigation Links
Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials
Date:4/22/2008

jects.

"The results of previous studies suggest that belimumab significantly reduced SLE disease activity in serologically active patients," said Professor Sandra V. Navarra, M.D., a principal investigator and head of Rheumatology at the University of Santo Tomas, Manila, Philippines. "There is a great need for better tolerated and more effective treatments for lupus, and we look forward to seeing the first Phase 3 data for belimumab by mid-2009."

About the LymphoStat-B Phase 3 Development Program

The LymphoStat-B Phase 3 development program includes two double-blind, placebo-controlled, multi-center Phase 3 superiority trials -- BLISS-52 and BLISS-76 -- to evaluate the efficacy and safety of LymphoStat-B plus standard of care, versus placebo plus standard of care, in patients with serologically active SLE. The design of the two trials is similar, but the duration of therapy in the two studies is different -- 52 weeks for BLISS-52 and 76 weeks for BLISS-76. The data from BLISS-76 will be analyzed after 52 weeks in support of a potential Biologics License Application (BLA). HGS designed the LymphoStat-B Phase 3 program in collaboration with GSK and leading international SLE experts.

"A total of nearly 1700 patients worldwide will be enrolled and randomized in the Phase 3 trials of belimumab, making this the largest double-blinded clinical development program ever undertaken in lupus patients," said William W. Freimuth, M.D., Ph.D., Vice President, Clinical Research - Immunology, Rheumatology and Infectious Diseases, HGS. "Today's milestone brings us closer to seeing Phase 3 data that we hope will confirm belimumab's promise as a potential treatment for patients with SLE. We are grateful for the superb performance of our clinical investigators, whose diligence made it possible to complete the enrollment of BLISS-52 ahead of our fall 2008 projection."

The primary efficacy endpoint of BLISS-52 and BLISS-76 is the patient response rate
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
2. Data Show SuperGens MP-470 is Safe in Humans
3. Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study
4. CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
5. Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
6. ExonHits EHT 0202 Counters Scopolamines Detrimental Effects on Cognition in Humans
7. Valor Medical Announces First Human Implant of Neucrylate AN(TM) for Treatment of Cerebral Aneurysm
8. Synbiotics Corporation Announces Human Submission for FluDetect(R)
9. GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
10. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
11. N30 Pharma Announces Successful Initiation of Human Studies With N30-201
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015  New York College of ... class Intellectual Properties portfolio with U.S. Patent #8,996,098 donated ... This patent represents a surgical instrument that allows surgeons ... if it were in the traditional format of a ... against medical databases during surgery, thus providing the surgeon ...
(Date:4/1/2015)... MOUNTAIN VIEW, Calif. , April ... BSX ) announces that it has signed a ... medical device company that develops, manufactures and sells ... transluminal drainage of targeted areas within the gastrointestinal ... week. The Xlumena portfolio includes ...
(Date:4/1/2015)... April 1, 2015  The first national study ... supplements to treat attention-deficit/hyperactivity disorder (ADHD) among children ... of children with ADHD were receiving behavioral therapy ... Control and Prevention (CDC) study, "Treatment of Attention-Deficit/Hyperactivity ... published today in The Journal of Pediatrics ...
Breaking Medicine Technology:Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3Boston Scientific Agrees to Acquire Xlumena 2Boston Scientific Agrees to Acquire Xlumena 3Boston Scientific Agrees to Acquire Xlumena 4Boston Scientific Agrees to Acquire Xlumena 5CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 3CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 4
... TRIANGLE PARK, N.C., Oct. 16 Liquidia,Technologies announces ... University of North Carolina-Chapel Hill professor, Joseph DeSimone. ... will discuss drug delivery,applications of the PRINT(TM) platform ... http://www.newscom.com/cgi-bin/prnh/20060614/CLW002LOGO ), -- Prostate ...
... Oct. 15 The following was,released today by ... conference call to discuss a new report from ... America,s Health (TFAH),"Pandemic Influenza: Warning, Children At-Risk." The ... caring for children during a possible,pandemic flu outbreak ...
Cached Medicine Technology:Targeted Nanoparticles Offer Promise in the Battle Against Cancer 2
(Date:4/1/2015)... York, NY (PRWEB) April 01, 2015 This ... partnering with the Oral Cancer Foundation for an Open House ... , from 9 a.m. to 4 p.m. An appointment is ... midtown dental office at 212-689-0024. In addition, Herald ... cancer screenings during the entire month of April at the ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Bird B ... industrial and residential applications now offers a complete line ... wide range of bird netting products quickly, safely and ... the success of any bird netting installation. It’s important ... the planning stages of a project. This includes deciding ...
(Date:4/1/2015)... LINCOLN, R.I. (PRWEB) April 01, 2015 After ... potholes. Driving over these potholes can lead to costly damage, ... your vehicle. , Amica is sharing the following suggestions from ... have plenty of tread and be inflated to the manufacturer’s ... change in vehicle handling, excessive vibration and uneven tire wear ...
(Date:4/1/2015)... April 01, 2015 Taking an important ... National League for Nursing Commission for Nursing Education Accreditation ... approved the first NLN CNEA Board of Commissioners. Working ... ANEF, the 15-member board will provide leadership and direction ... all accreditation decisions for nursing programs that seek accreditation ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 BioPlus ... innovative specialty pharmacies, has released a new app to ... guidelines for treating chronic hepatitis C virus (HCV) infection. ... based on information from the American Association for the ... sources. , Numerous new direct-acting oral medications to treat ...
Breaking Medicine News(10 mins):Health News:Herald Square Dental Celebrates Oral Cancer Awareness Month 2Health News:Bird B Gone Now Carries Complete Bird Netting Hardware 2Health News:Bird B Gone Now Carries Complete Bird Netting Hardware 3Health News:Prepare for potholes with 7 tips from Amica Insurance 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 3Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2
... Medical ... powerful partners for creating high quality medical transcriptions. , ... Scottsdale, AZ, (PRWEB) June 25, 2009 -- ... store medical information, but a physician,s dictation technique still plays a critical role in ...
... and Federal Healthcare Policy and Regulatory Team , ... the largest law firms in Florida and one of ... the expansion of its Healthcare practice with significant additions ... professionals have joined the practice in the firm,s Washington, ...
... German . , If you have hay ... to the nearest chemist. The drugs, on the other hand, ... animal experiments have been an essential step, yet they continue ... at offering an alternative to animal experiments," says Professor Heike ...
... ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer ... announced participation in the upcoming joint meeting of the Society ... which is being held in Berlin on June 27-30, 2009. ... surgeons from around the world and provides an excellent venue ...
... UPMC Health Plan One of 17 Platinum-Level Award winners ... Health Plan have been honored by the National Business Group ... for innovative programs that promote a healthy workplace and for ... about their own health and well-being. , , UPMC ...
... Putting Patients First , , PRINCETON, N.J., June 25 ... for sponsoring legislation that will improve access to behavioral health ... , , Surveys have shown that N.J. patients have ... transfer to an appropriate behavioral health program. (see below.) ...
Cached Medicine News:Health News:Medical Transcription Services Company MxSecure, Inc. Announces Top Ten Dictation Tips for Physicians 2Health News:Medical Transcription Services Company MxSecure, Inc. Announces Top Ten Dictation Tips for Physicians 3Health News:Akerman Senterfitt Announces Expansion of Healthcare Practice 2Health News:Akerman Senterfitt Announces Expansion of Healthcare Practice 3Health News:Artificial liver for drug tests 2Health News:ATS Medical Announces Participation in the Joint Meeting of the Society for Heart Valve Disease and Heart Valve Society of America 2Health News:ATS Medical Announces Participation in the Joint Meeting of the Society for Heart Valve Disease and Heart Valve Society of America 3Health News:ATS Medical Announces Participation in the Joint Meeting of the Society for Heart Valve Disease and Heart Valve Society of America 4Health News:UPMC and UPMC Health Plan Recognized by National Business Group on Health As a Leading Employer Promoting Healthy Lifestyles for Its Employees 2Health News:UPMC and UPMC Health Plan Recognized by National Business Group on Health As a Leading Employer Promoting Healthy Lifestyles for Its Employees 3Health News:Bills Address Long Waits for Behavioral Health Patients 2Health News:Bills Address Long Waits for Behavioral Health Patients 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: